PATENT CLAIM ANALYSIS

Application Number: 15757608
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-08
Patent Classification: ["424", "001370"]

Abstract:
Pharmaceutical composition containing poly(bile) acid (PBA) polymers for oral delivery of agent(s) show enhanced uptake by the pancreas, liver, and colon. These nanoparticles show significant retention in the pancreas and colon and are therefore useful for selective delivery. The examples demonstrate efficacy of oral administration of insulin to treat diabetes, and oral induction of tolerance by administration of insulin or ovalbumin in combination with rapamycin. Diabetic animals treated with the insulin or insulin with rapamycin showed normalization of blood glucose levels.

Claim (Index 6):
The formulation of  claim 5  wherein the agent is selected from the group consisting of antigens, cytokines, hormones, antiinfectives, antiproliferatives, anti-inflammatory agents, and immunomodulatory agents.

Metadata:
- Claim Count in Document: 16.0
- Percentile: 90.0
- Lexical Diversity: 1.6
- Patent Class: 424.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14394147', '15434971', '12322443', '12378976', '12459657']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7717477612052377
- 35 USC 102 Novelty (BERT): 0.5103394502892469
- Combined Prediction Score: 0.7456069301136387
- Mean Citation Score: 282.191246
- Max Citation Score: 296.7619
- Similarity Product: 220.91384619497063

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test